Literature DB >> 16807088

Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice.

Hui-Young Lee1, Jong-Hwan Park, Seung-Hyeok Seok, Min-Won Baek, Dong-Jae Kim, Ki-Eun Lee, Kyung-Soo Paek, Yeonhee Lee, Jae-Hak Park.   

Abstract

Many previous studies have reported that conjugated linoleic acid could be produced by starter culture bacteria, but the effects of the bacteria were not investigated. Moreover, there was no evidence of the conjugated linoleic acid-producing bacteria having potential health or nutritional effects related to conjugated linoleic acid, including reducing body fat. Here, we investigated the anti-obesity effect of Lactobacillus rhamnosus PL60, a human originated bacterium that produces t10, c12-conjugated linoleic acid, on diet-induced obese mice. After 8 weeks of feeding, L. rhamnosus PL60 reduced body weight without reducing energy intake, and caused a significant, specific reduction of white adipose tissue (epididymal and perirenal). Although the size of epididymal adipocytes was not reduced by L. rhamnosus PL60, apoptotic signals and UCP-2 mRNA levels increased in adipose tissue. Liver steatosis, a well known side effect of CLA, was not observed by L. rhamnosus PL60 treatment; on the contrary it seemed to be normalized. Results showed that the amount of conjugated linoleic acid produced by Lactobacillus rhamnosus PL60 was enough to produce an anti-obesity effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807088     DOI: 10.1016/j.bbalip.2006.05.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  85 in total

1.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 2.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 3.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 4.  Effects of gut microbes on nutrient absorption and energy regulation.

Authors:  Rosa Krajmalnik-Brown; Zehra-Esra Ilhan; Dae-Wook Kang; John K DiBaise
Journal:  Nutr Clin Pract       Date:  2012-02-24       Impact factor: 3.080

Review 5.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

7.  Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4).

Authors:  Linda Aronsson; Ying Huang; Paolo Parini; Marion Korach-André; Janet Håkansson; Jan-Åke Gustafsson; Sven Pettersson; Velmurugesan Arulampalam; Joseph Rafter
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  Probiotics and their Effects on Metabolic Diseases: An Update.

Authors:  Juhi Aggarwal; Gaurav Swami; Mayur Kumar
Journal:  J Clin Diagn Res       Date:  2013-01-01

Review 9.  The gut microbiota in human energy homeostasis and obesity.

Authors:  Michael Rosenbaum; Rob Knight; Rudolph L Leibel
Journal:  Trends Endocrinol Metab       Date:  2015-08-07       Impact factor: 12.015

10.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.